Istanbul, Turkey

Serkan Atmaca

This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignee: Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi. Active years: 2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Serkan Atmaca: Innovator in Intraocular Lens Technology

Introduction

Serkan Atmaca is a notable inventor based in Istanbul, Turkey. He has made significant contributions to the field of ophthalmology through his innovative inventions. His work primarily focuses on improving the methods of intraocular lens implantation.

Latest Patents

Serkan Atmaca holds a patent for an invention titled "Ancillary for the storage and the injection of intraocular lens." This invention relates to a cartridge injector system designed for intraocular lens implantation. It enables the lens to be injected through a microsurgical incision in the eye. The system wraps the lens by holding it from the edges, facilitating the implantation process. Additionally, it features a twisting body that keeps the lens in a closed environment until it is ready for use.

Career Highlights

Serkan Atmaca is associated with Vsy Biyoteknoloji ve Ilac Sanayi Anonim Sirketi, a company that focuses on biotechnological advancements and pharmaceuticals. His work at this company has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Some of his notable coworkers include Pascal Bernard and Faruk Oytun. Their collaboration has contributed to the development of advanced technologies in the field of ophthalmology.

Conclusion

Serkan Atmaca's contributions to intraocular lens technology demonstrate his commitment to innovation in the medical field. His patent reflects a significant advancement in surgical techniques, enhancing the quality of care for patients undergoing lens implantation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…